Kenvue Inc.

Money Moves

Removed from the S&P 500 on Nov. 4 as Kimberly-Clark's acquisition proceeds

Okta joined the S&P 500 before the market opened on Nov. 4, filling the seat Kenvue gave up as Kimberly-Clark's roughly $40 billion purchase of the consumer-health company nears completion. The identity-software maker also entered the index's information-technology and other sector sub-indexes and left the S&P MidCap 400.

Updated 6 days ago

New Capabilities

As of August 2026: Plans to use bemotrizinol in its brands

For more than 25 years, US sunscreen makers worked from the same short list of ultraviolet filters. On August 9, 2026, an FDA order let them start using a new one.

Updated Aug 9

Money Moves

As of May 2026: Acquisition target

Johnson & Johnson spun off its consumer health division as Kenvue in May 2023, creating the world's largest pure-play consumer health company. In less than three years, Kimberly-Clark and Kenvue shareholders approved a $48.7 billion acquisition absorbing Kenvue into Kimberly-Clark, the Kleenex and Huggies maker—with 96% and 99% voting in favor. On January 30, 2026, The Lancet published a study finding no evidence linking acetaminophen use during pregnancy to autism, contradicting Trump administration concerns that sent Kenvue's stock tumbling in late 2025.

Updated May 23